These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21966049)

  • 1. RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside.
    Zeller SJ; Kumar P
    Yale J Biol Med; 2011 Sep; 84(3):301-9. PubMed ID: 21966049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae.
    Rigden JE; Ely JA; Macpherson JL; Gerlach WL; Sun LQ; Symonds GP
    Curr Issues Mol Biol; 2000 Apr; 2(2):61-9. PubMed ID: 11471565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.
    von Eije KJ; Berkhout B
    Antivir Chem Chemother; 2009; 19(6):221-33. PubMed ID: 19641231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.
    Zhou J; Rossi J
    J Investig Med; 2014 Oct; 62(7):914-9. PubMed ID: 25118114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
    Morris KV; Rossi JJ
    Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
    Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
    Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-based therapeutics: current progress and future prospects.
    Burnett JC; Rossi JJ
    Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy strategies to block HIV-1 replication by RNA interference.
    Herrera-Carrillo E; Berkhout B
    Adv Exp Med Biol; 2015; 848():71-95. PubMed ID: 25757616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1.
    Ramezani A; Ma XZ; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a29-36. PubMed ID: 11815297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques.
    Braun SE; Johnson RP
    Front Biosci; 2006 Jan; 11():838-51. PubMed ID: 16146775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic therapy for HIV/AIDS.
    Poluri A; van Maanen M; Sutton RE
    Expert Opin Biol Ther; 2003 Sep; 3(6):951-63. PubMed ID: 12943454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Interference Therapies for an HIV-1 Functional Cure.
    Scarborough RJ; Gatignol A
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29280961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and Ribozymes.
    Scarborough RJ; Gatignol A
    Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.
    Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S
    Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small RNAs to treat human immunodeficiency virus type 1 infection by gene therapy.
    Goguen RP; Malard CM; Scarborough RJ; Gatignol A
    Curr Opin Virol; 2019 Oct; 38():10-20. PubMed ID: 31112858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.